Intuitive Surgical 3Q Profit Up On More Procedures Using Its Robotic-Surgery System
By Paul Ziobro
Intuitive Surgical posted higher third-quarter profit due to a double-digit increase in procedures using its robotic-surgery system.
The Sunnyvale, Calif.-based company on Thursday reported a profit of $415.7 million , or $1.16 share, compared with a profit of $324 million, or 90 cents a share, in the same quarter last year.
Excluding one-time items, the company reported earnings of $1.46 a share. Analysts recently polled by FactSet expected $1.42 a share.
Revenue rose 12% to $1.74 billion, compared with analyst expectations of $1.77 billion.
Instruments and accessories revenue rose by 23% to $1.07 billion, helped by a 19% increase in procedures using its da Vinci system and higher prices.
The company said its installed base of da Vinci systems stood at 8,285 at the end of the third-quarter, up 13% from a year ago.
Write to Paul Ziobro at paul.ziobro@wsj.com
(END) Dow Jones Newswires
October 19, 2023 16:40 ET (20:40 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back